Cyclomedica Danmark ApS: Financial statements 2025
CVR: 16582891
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Cyclomedica Danmark ApS (CVR 16582891) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 559,660 and a net result of DKK 135,961 compared with DKK -5,806 the year before. That is a decrease of 26.9% compared with the year before. Equity in the 2025 report amounted to DKK 478,864. The solvency ratio was 34.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 559,660
- Profit/Loss
- DKK 135,961
- Equity
- DKK 478,864
- Total Assets
- DKK 1,395,607
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 560K | 136K | 479K | 1 |
| 2024 | - | 766K | -6K | 343K | 2 |
| 2023 | - | 831K | -188K | 349K | 2 |
| 2022 | - | 622K | -394K | 1M | 3 |
| 2021 | - | 671K | -379K | 1.4M | 3 |
Official annual report
How creditworthy is Cyclomedica Danmark ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Cyclomedica Danmark ApS has published its annual report for 2024. Gross profit came to DKK 765,707, and the net result was DKK -5,806.
About Cyclomedica Danmark ApS
Cyclomedica Danmark ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named DUPHARMA ApS and DUPHARMA A/S. The management consists of Jan Fritz Rode Jakobsen. The board consists of James Steven Mc Brayer and Mathew Farag. The company is owned by Cyclomedia Europe Limited. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 559,660 and a net result of DKK 135,961 compared with DKK -5,806 the year before. Equity in the 2025 report amounted to DKK 478,864.